Pnc Financial Services Group, Inc. Vaxcyte, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,679 shares of PCVX stock, worth $622,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,679
Previous 8,444
9.06%
Holding current value
$622,459
Previous $637,000
37.52%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PCVX
# of Institutions
355Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$927 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$885 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$806 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$704 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$397 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.81B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...